Advanced / Aggressive Approach (1 mL = 10 mg/mL) Note: Advanced dosing (1520 mg/day) is based on shortterm clinical trial protocols [4] [5] for severe mitochondrial conditions and should only be pursued under medical supervision
The single human trial anyone can point to did not test MOTS-c
2009) and bone (ebei et al
TB-500 (Thymosin Beta-4 Fragment) 500MCG Carrier matrix: non-toxic, transdermal adhesive (No fillers, no preservatives, no parabens) The patch delivers peptides transdermally over 68 hours no needles, no pain, and great for localized application on injured areas
Reputable suppliers use appropriate cold-chain handling and expedited shipping to maintain product integrity
As part of the Brain Well Program, we integrate TMS to enhance brain healing, supporting long-term mental wellness without relying solely on medication